Qalhat Capital Ltd historic quarter change: USA ETF, Added
In exchange-traded fund shares (known by the fund name on the filing) (listed in the US), over 8 quarters from 2023-12-31 to 2025-12-31, Qalhat Capital Ltd opened 2 positions, added to 8, reduced 3 and sold out of 4.
- Q3 2025: Stock IWF; Country of operation —; Class RUS 1000 GRW ETF; Shares before 250,930.
- Q2 2025: Stock ACWI; Country of operation —; Class MSCI ACWI ETF; Shares before 2,451,072.
- Q2 2025: Stock IVV; Country of operation —; Class CORE S&P500 ETF; Shares before 175,317.
- Q2 2025: Stock IWF; Country of operation —; Class RUS 1000 GRW ETF; Shares before 227,166.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1884252), 8 quarters: Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-01-12); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2021-12-31.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| CHEVRON CORP | United States | $0.000B | 0 |
| PITCAIRN CO | United States | $0.000B | 1 |
| KEYSTONE GROUP, L.P. | United States | $0.000B | 0 |
| Sarepta Therapeutics, Inc. | United States | $0.000B | 1 |
| BASS LEE M /TX/ | United States | $0.000B | 0 |
| PROVIDA PENSION FUND ADMINISTRATOR | Chile | $0.000B | 1 |
| FIRST CITIZENS INVESTOR SERVICES, INC. | United States | $0.000B | 23 |
| LVM CAPITAL MANAGEMENT LTD/MI | United States | $0.000B | 0 |
| GENRE PARTNERS L P | United States | $0.000B | 0 |
| Scepter Holdings, Inc. | United States | $0.000B | 1 |